Vanguard Extended Market ETF Newsroom

Trending Stocks as U.S.market Posts Another Week of Rebound

Seeking Alpha13:21 ET

UBS Maintains Neutral on Atlassian, Lowers Price Target to $215

BenzingaMay 2 19:04 ET · Ratings

$100 Invested In CRH 5 Years Ago Would Be Worth This Much Today

BenzingaMay 2 17:30 ET

An Overview of CRH's Earnings

BenzingaMay 2 17:02 ET

Catalyst Watch: Powell Presser, AMD Earnings, IBM Event, and Lions Gate Splits in Two

Seeking AlphaMay 2 15:00 ET

These Analysts Cut Their Forecasts On Atlassian After Q3 Results

BenzingaMay 2 14:18 ET

Bitcoin on Course to Inch Upwards, on Course to Rise 2.9% W/W

Seeking AlphaMay 2 14:16 ET

8 Information Technology Stocks With Whale Alerts In Today's Session

BenzingaMay 2 13:35 ET

New MST ETF Mixes MicroStrategy (Strategy) Leverage With A Side Of Weekly Income

BenzingaMay 2 13:15 ET

EToro Eyes U.S. IPO Launch as Soon as Next Week After Delay - Report

Seeking AlphaMay 2 13:05 ET

What's Going On With MicroStrategy Shares?

BenzingaMay 2 11:58 ET

Piper Sandler Reiterates Overweight on Atlassian, Lowers Price Target to $300

BenzingaMay 2 10:41 ET · Ratings

Atlassian Analyst Ratings

BenzingaMay 2 10:40 ET · Ratings

Marvell Tech's Options: A Look at What the Big Money Is Thinking

BenzingaMay 2 10:00 ET

Warren Buffett's Compounders Crush Cathie Wood's Disruptors Over The Long Haul

BenzingaMay 2 08:52 ET

Today's Pre-Market Movers and Top Ratings | AMZN, AAPL, DOUL and More

Movers and ShakersMay 2 08:51 ET

Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session

BenzingaMay 2 08:04 ET

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday

BenzingaMay 2 07:57 ET

Chardan Capital Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $325

BenzingaMay 2 07:04 ET · Ratings

Alnylam Pharmaceuticals Analyst Ratings

BenzingaMay 2 07:02 ET · Ratings